Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with stage 1 or stage 2 high blood pressure
- People who have been receiving regular treatment for their high blood pressure for more than 6 months
- People whose blood pressure medication doses have not changed in the last three months
Who may not be able to join:
- People who have an autoimmune condition, an active infectious disease, or diabetes
- People who have chronic kidney disease, liver disease, cancer, or AIDS
- People who are pregnant
- People who are currently taking catabolic drugs (medicines that break down body tissue) or antibiotics
- People who are currently taking antioxidant vitamin supplements, prebiotics, probiotics, or synbiotics (combinations of prebiotics and probiotics)
- People who regularly consume royal jelly or propolis (natural bee-derived products)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ludmila Cardozo, PhD, Universidade Federal Fluminense
Phone: +5521985683003
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change of inflammatory citokynes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.